Palpitations in Young People: 2 ECG Challenges

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Inclisiran can now be used without a background statin, as an adjunct to changes in diet and physical activity for reduction of LDL-C in hypercholesterolemia.

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.

Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida

Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.

FDA Label Update Positions Inclisiran as First-Line Monotherapy for Hypercholesterolemia

Weight cycling significantly raises heart failure and metabolic disease risks, independent of baseline overweight, underscoring the importance of stable weight strategies.

Related Content

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Inclisiran can now be used without a background statin, as an adjunct to changes in diet and physical activity for reduction of LDL-C in hypercholesterolemia.

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.

Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Weight Cycling Ups Risk for Heart Failure by 50%, Other Metabolic Diseases by Up to 30%: New Data

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.